drugset / Trial / NCT00002974
Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma
Phase 2
Completed
34 enrolled
University of Wisconsin, Madison
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Hyperthermia therapy kills tumor cells by heating them to several degrees above body temperature. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with whole-body hyperthermia may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of whole-body hyperthermia plus combination chemotherapy in treating patients who have advanced sarcoma that is metastatic or that cannot be surgically removed.
Timeline
- Start
- 1996-07
- Primary completion
- 2001-07
- Completion
- 2003-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | Intravenous |
| Subject | Etoposide | Small molecule | — | Intravenous |
| Subject | Ifosfamide | Small molecule | — | Intravenous |